Hiromi Gotou

Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension

Kazuomi Kario, Ningling Sun, Fu‐Tien Chiang et al. · Hypertension · 2014 · 228 citations

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction

Sadayoshi Ito, Minoru Satoh, Yuko Tamaki et al. · Hypertension Research · 2015 · 105 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Aliskiren, a Novel Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Placebo-Like Tolerability in Japanese Patients with Hypertension

Toshio Kushiro, Hiroshige Itakura, Yoshihisa Abo et al. · Hypertension Research · 2006 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

Hiromi Rakugi, Kazuomi Kario, Masako Yamaguchi et al. · Hypertension Research · 2022 · 75 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +13

<scp>LCZ</scp>696, a First‐in‐Class Angiotensin Receptor‐Neprilysin Inhibitor: The First Clinical Experience in Patients With Severe Hypertension

Kazuomi Kario, Yuko Tamaki, Naoko Okino et al. · Journal of Clinical Hypertension · 2015 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17